01—Abstract
Summary
Summary of the 20-F filed May 20, 2025. Cited figures are marked; the original filing is the authoritative source.
James Hardie Industries plc reported fiscal year 2025 (year ended 31 March 2025) net sales of US$3,877.5 milliona, down from US$3,936.3 million in FY24, with operating income of US$655.9 million (versus US$767.4 million) and net income of US$424.0 million (versus US$510.2 million).
Diluted EPS was US$0.98b compared with US$1.16. The decline was driven mainly by lower volumes in North America and Asia Pacific, lower North American gross margin, restructuring charges of US$50.3 million tied to closing Philippines operations, US$16.5 million of merger costs, and asbestos-related expenses and adjustments of US$140.5 million. Management reported Adjusted EBIT of US$863 million and Adjusted net income of US$644 million for the year.
The most significant pending event is the merger agreement with The AZEK Company Inc., signed in March 2025 for a combination of cash and James Hardie shares, with closing expected in the second half of calendar 2025 subject to AZEK shareholder approval and regulatory clearance. The company secured a bridge commitment of up to US$4.3 billionc and expects total debt of approximately US$4.4 billion after closing, compared with US$1.1 billion at 31 March 2025. Management guided that US employee residential end markets will be down in fiscal 2026, with Repair and Remodel expected to decline more than New Construction, while Australia and Europe addressable markets are expected to be flat.
Balance sheet and cash flow remained solid, with cash of US$562.7 milliond, gross debt of US$1,124.0 million, and net cash from operating activities of US$802.8 million. The company repurchased 4.5 million shares for US$149.9 million and expects to pay about A$185 million to the asbestos fund AICF in fiscal 2026. The asbestos liability stood at US$983.6 million at 31 March 2025.
02—Key points
Key Highlights
- Net sales fell to US$3,877.5 million from US$3,936.3 million, with operating income down to US$655.9 million from US$767.4 million.
- Net income declined to US$424.0 million (diluted EPS US$0.98) from US$510.2 million (US$1.16).
- Gross margin decreased to 38.8% from 40.4%, mainly due to lower North America gross margin and higher pulp and cement costs.
- Pending AZEK merger, expected to close in the second half of calendar 2025, would raise total debt to approximately US$4.4 billion from US$1.1 billion.
- Management expects US residential end markets to decline in fiscal 2026, with Repair and Remodel falling more than New Construction.
- Operating cash flow was US$802.8 million, and the company repurchased US$149.9 million of shares, though it does not expect further buybacks until the AZEK merger closes.
- Asbestos-related expenses and adjustments were US$140.5 million, and the asbestos liability totaled US$983.6 million at 31 March 2025.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2025, James Hardie Industries kept $0.11.
- Revenue$3.88B100.0%
- Cost of revenue−$2.37B61.2%
- Gross profit$1.50B38.8%
- Operating costs−$849.1M21.9%
- Operating income$655.9M16.9%
- Interest, other & tax−$231.9M6.0%
- Net income$424.0M10.9%
Where FY2025 revenue went
$3.88B- Cost of revenue: $2.37B, 61% of revenue
- SG&A: $596.2M, 15% of revenue
- Net income: $424.0M, 11% of revenue
- R&D: $48.5M, 1.3% of revenue
- Other operating costs: $204.4M, 5.3% of revenue
- Interest, other & tax: $231.9M, 6.0% of revenue
Kept 11% as net incomeR&D $48.5M · 1.3%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2025filed May 20, 2025Financial Statements
FY2025 against FY2024
| Line item | FY2025FY2024 | Change |
|---|---|---|
| Revenue | $3.88B$3.94B | −1.5% |
| Cost of Revenue | $2.37B$2.35B | +1.0% |
| Gross Profit | $1.50B$1.59B | −5.3% |
| R&D Expenses | $48.50M$47.00M | +3.2% |
| SG&A Expenses | $596.20M$602.20M | −1.0% |
| Operating Income | $655.90M$767.40M | −14.5% |
| Net Income | $424.00M$510.20M | −16.9% |
| EPS (Basic) | $0.98$1.16 | −15.5% |
| EPS (Diluted) | $0.98$1.16 | −15.5% |
| Shares Outstanding (Basic) | 430.80M438.40M | −1.7% |
| Shares Outstanding (Diluted) | 432.10M439.60M | −1.7% |
05—Questions
Frequently Asked Questions
Why did James Hardie's profitability decline in fiscal 2025?
Operating income fell 15% to US$655.9 million, driven by lower North America volumes and gross margin, higher SG&A, US$50.3 million of restructuring costs for the Philippines closure, US$16.5 million of AZEK merger costs, and US$137.6 million of asbestos adjustments. Net sales were down 1% to US$3,877.5 million.
What is the AZEK acquisition and how will it change the company's balance sheet?
In March 2025 James Hardie agreed to acquire The AZEK Company Inc. for a combination of cash and shares, with each AZEK share receiving US$26.45 in cash and 1.0340 James Hardie shares. The company expects debt to rise to about US$4.4 billion after closing from US$1.1 billion, and the transaction is subject to AZEK shareholder approval and regulatory conditions.
What is the outlook for fiscal 2026?
The company expects US residential end markets to be down in fiscal 2026, with Repair and Remodel decreasing more than New Construction. Australia and Europe addressable markets are expected to be flat, and James Hardie expects to outperform end markets in all three segments. Capital expenditures are estimated at about US$325 million.
How is James Hardie funding its asbestos obligations?
James Hardie funds the Asbestos Injuries Compensation Fund under the AFFA. It funded A$149.6 million (US$99.2 million) in fiscal 2025 and expects to contribute approximately A$185 million (US$116 million) in fiscal 2026. The asbestos liability was US$983.6 million at 31 March 2025.
How strong is the company's liquidity position?
At 31 March 2025, cash and cash equivalents were US$562.7 million and gross debt was US$1,124.0 million, with no borrowings on the US$600 million revolving credit facility. In April 2025 the company repaid its US$295.3 million term loan using existing cash, and it expects sufficient funds for the next twelve months.
06—Continue